Menu
Recruiting NCT05783245

Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release

No phase Interventional Carpal Tunnel Syndrome Perioperative/Postoperative Complications

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Polarcare Machine, Standard of care ice therapy.
Who it may be relevant to
Registry conditions: Carpal Tunnel Syndrome, Perioperative/Postoperative Complications. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study seeks to perform an appropriately-powered study to evaluate any clinical difference between continuous cooling therapy and traditional ice for treatment of post-operative pain in open CTR surgery.

Detailed description

Post-operative pain control is paramount to all operative procedures and involves several modalities. Both pharmaceutical and non-pharmaceutical measures are frequently used. Carpal tunnel release (CTR) surgery is one of the most common surgeries performed in the U.S. with over 400,000 procedures per year.2 Frequently, ice is used as a treatment modality following surgical CTR.3 Several products have been developed in the past decades to improve ice therapy in the rehabilitation period. One such product is the Polar Care which provides up to 6-8 hours of continuous icing.

While there is good data supporting the use of cooling therapy (ice) for post-operative pain, there is lack of data surrounding the use of continuous cooling therapy machines such as the PolarCare following carpal tunnel release (CTR). The two papers that evaluated the efficacy of continuous cooling therapy following CTR had conflicting results on any added benefit of continuous cooling therapy over traditional icing.

There is no standard of care for post-operative icing at UCMC following CTR. Clinicians currently decide whether to give patients a PolarCare machine on the day of surgery without any algorithm. All other patients are encouraged to use traditional icing methods. This study seeks to perform an appropriately-powered study to evaluate any clinical difference between continuous cooling therapy and traditional ice for treatment of post-operative pain in open CTR surgery.

The investigators hypothesize that participants receiving continuous cooling therapy will have a statistically significantly lower pain score compared to those receiving traditional ice therapy.

Interventions

  • Other Polarcare Machine
    Use of Polar Care ice machine as often as possible, but a minimum of three 15 minute uses per day, for the first 3 days after surgery. No single use should last longer than 30 minutes.
  • Other Standard of care ice therapy
    Use of commercial reusable ice packs as often as possible, but a minimum of three 15 minute uses per day, for the first 3 days after surgery. No single use should last longer than 30 minutes.

Primary outcome measures

  • Visual Analog Scale (VAS) for pain [Time frame: 3 days]
Secondary outcome measures (1)
  • Disabilities of the Arm, Shoulder, and Hand questionnaire [Time frame: 1 week]

Eligibility criteria

Inclusion criteria

  • Age 18 or older
  • Indicated for open carpal tunnel release
  • Able and willing to complete online questionnaires

Exclusion criteria

  • Prior carpal tunnel surgery for ipsilateral extremity
  • Additional procedures to be performed on ipsilateral or contralateral extremity
  • Current opioid or narcotic pain medication usage

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • University of Chicago Medicine — Chicago

Identifiers

NCT: NCT05783245 · IRB21-1298

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗